Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hydron Technologies is a specialty healthcare company focused on the development and commercialization of products utilizing its proprietary Hydron polymer technology, a medical-grade hydrogel. Originally famous for the development of the foundational material for soft contact lenses (poly-HEMA), the company pivoted to focus on topical drug delivery systems and high-performance skincare products. Its technology platform is designed to enhance the delivery of active ingredients to the skin while providing a protective, breathable barrier. The company's portfolio included the "Best of Both Worlds" skincare line and licensed applications in pharmaceutical delivery, most notably the Cervidil vaginal insert. While historically significant in the dermatology and medical device sectors, the company has become largely inactive in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hydron Technologies.